First large-scale population analysis reinforces ketamine's reputation as antidepressant
Wednesday, May 3, 2017 - 09:51
in Health & Medicine
Researchers have mined the FDA Adverse Effect Reporting System (FAERS) database for depression symptoms in patients taking ketamine for pain. They found that depression was reported half as often among the more than 41,000 patients who took ketamine, as compared to patients who took any other drug or drug combination for pain.